Scarica l'app Stockscreener
19.60
8.59%
1.55
Dopo l'orario di chiusura:
19.51
-0.09
-0.46%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLP Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Simulations Plus Inc Borsa (SLP) Ultime notizie
Simulations Plus, Inc. SEC 10-Q Report - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Bio-Techne (TECH) and Simulations Plus (SLP) - The Globe and Mail
Simulations Plus, Inc. (NASDAQ:SLP) Q1 2026 Earnings Call Transcript - Insider Monkey
SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales - TradingView — Track All Markets
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... By GuruFocus - Investing.com Canada
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Is Simulations Plus Inc. stock overvalued by current metricsJuly 2025 Closing Moves & Stepwise Swing Trade Plans - ulpravda.ru
Simulations Plus Q1 2026 Earnings Call Transcript - MarketBeat
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results - PharmiWeb.com
Simulations Plus, Inc. Q1 Profit Increases, But Misses Estimates - Nasdaq
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast By Investing.com - Investing.com Nigeria
Simulations Plus Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast - Investing.com
Simulations Plus Inc (NASDAQ:SLP) Meets Q1 Revenue Target Amid Software Segment Decline - Chartmill
Is Simulations Plus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - ulpravda.ru
Can Simulations Plus Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Capital Efficiency Focused Ideas - ulpravda.ru
Simulations Plus: Overview of First Quarter Financial Results - Bitget
Simulations Plus: Fiscal Q1 Earnings Snapshot - KVUE
SLP Adjusts FY26 Revenue Forecast Between $79M and $82M - GuruFocus
Simulations Plus Fiscal Q1 Adjusted EPS, Revenue Decrease - MarketScreener
Simulations Plus earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Simulations Plus Posts Mixed Q1 2026 Results, Reaffirms Outlook - TipRanks
Simulations Plus (NASDAQ:SLP) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS - MarketBeat
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat - Investing.com India
Simulations Plus Q1 revenue beats expectations - TradingView — Track All Markets
Simulations Plus, Inc. Reaffirms Earnings Guidance for Fiscal 2026 - MarketScreener
SLP: Analyst Maintains Rating and Raises Price Target to $19.00 - GuruFocus
Simulations Plus (NASDAQ:SLP) Price Target Raised to $19.00 - MarketBeat
Tributary Capital Management LLC Grows Stock Holdings in Simulations Plus, Inc. $SLP - MarketBeat
Will Simulations Plus Inc. stock benefit from green energy trendsMACD Trading Signals & Real-Life Case Studies You Can Follow - ulpravda.ru
An Overview of Simulations Plus's Earnings - Benzinga
North Star Investment Management Corp. Acquires 111,255 Shares of Simulations Plus, Inc. $SLP - MarketBeat
Citizens maintains Simulations Plus stock rating ahead of earnings By Investing.com - Investing.com Canada
Simulations Plus Q1 2025 Earnings Preview - MSN
Simulations Plus drives advancements in CAR-T therapy kinetics - Traders Union
What drives Simulations Plus Inc stock priceTrading Volume Trends & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat By Investing.com - Investing.com Nigeria
Simulations Plus (SLP) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Signal Recap: Will Simulations Plus Inc stock outperform Nasdaq indexJuly 2025 Chart Watch & AI Optimized Trade Strategies - moha.gov.vn
Simulations Plus (NASDAQ: SLP) details 2026 meeting, auditor and equity plan votes - Stock Titan
Simulations Plus (FRA:SD3) Intrinsic Value: Projected FCF : €10.77 (As of Dec. 27, 2025) - GuruFocus
Guidance Update: Is PCGPRH stock overvalued by current metricsJuly 2025 PreEarnings & Low Volatility Stock Suggestions - moha.gov.vn
Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Viridian Therapeutics (VRDN) - The Globe and Mail
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Simulations Plus (SLP) Highlights FDA Alignment as Citizens Maintains Market Perform - Insider Monkey
Diluted shares outstanding of Simulations Plus, Inc. – FWB:SD3 - TradingView — Track All Markets
Current ratio of Simulations Plus, Inc. – FWB:SD3 - TradingView — Track All Markets
Can Simulations Plus Inc. stock deliver strong Q4 earnings2025 Historical Comparison & High Return Stock Watch Alerts - DonanımHaber
Will Simulations Plus Inc. stock attract more institutional investorsQuarterly Profit Report & Weekly Top Gainers Trade List - DonanımHaber
Trading Recap: Will Simulations Plus Inc. stock benefit from green energy trendsMarket Sentiment Report & Fast Gaining Stock Reports - Улправда
Simulations Plus (SLP) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com
Will Simulations Plus Inc. stock maintain growth story2025 Institutional Moves & Daily Market Momentum Tracking - Улправда
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - 01net
SLP Downgraded to Neutral by BTIG Analyst David Larsen | SLP Sto - GuruFocus
6.07%
0.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):